Latest Articles
Lunresertib Plus Camonsertib Produces Durable Responses in Advanced Endometrial, Ovarian Cancer - OncLive
Lunresertib Plus Camonsertib Produces Durable Responses in Advanced Endometrial, Ovarian Cancer OncLive
Published: Dec. 19, 2024, 4:30 p.m.
GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion - MSN
GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion MSN
Published: Dec. 19, 2024, 1:50 p.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today
Published: Dec. 18, 2024, 8:16 p.m.
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer - Medpage Today
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:59 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:27 p.m.
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE
Published: Dec. 18, 2024, 12:25 p.m.
Molecular Classification Drives Advances in Endometrial Cancer Treatment - Journal of Clinical Pathways
Molecular Classification Drives Advances in Endometrial Cancer Treatment Journal of Clinical Pathways
Published: Dec. 17, 2024, 3:25 p.m.
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission - MSN
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission MSN
Published: Dec. 17, 2024, 1:27 p.m.
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com India
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com India
Published: Dec. 16, 2024, 7:47 p.m.
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com
Published: Dec. 16, 2024, 5:30 p.m.
Link copied to clipboard!